Share Name Share Symbol Market Type Share ISIN Share Description
Integumen Plc LSE:SKIN London Ordinary Share GB00BMGWZY29 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 28.00 28.00 29.00 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Personal Goods 0.8 -2.4 0.3 93.3 32

Deepverge PLC Related Party Transaction

26/11/2021 7:00am

UK Regulatory (RNS & others)

Integumen (LSE:SKIN)
Historical Stock Chart

From Oct 2021 to Jan 2022

Click Here for more Integumen Charts.


RNS Number : 6612T

Deepverge PLC

26 November 2021


26 November 2021

DeepVerge plc ("DeepVerge" or "Company")

Related Party Transaction

DeepVerge announces that it is proposing to settle for cash, obligations to certain Directors relating to their salaries which are currently contracted to be settled in shares in the Company. The Directors concerned have agreed, in the best interests of the Company and shareholders, to forego significant potential gains on these shares in return for a cash sum, which is calculated based on a 25% uplift on the original value of the salary obligations. This situation has arisen following a significant rise in the Company's share price since these arrangements were made in 2018.

Ross Andrews, Chairman of DeepVerge, said:

"DeepVerge has been through transformational change since the appointment of Gerry and Camillus in 2018. Under their leadership, the Company has been streamlined to focus on developing a successful revenue-generating environmental and healthcare business, with revenues increasing year-on-year by more than 300%.

On behalf of the Board, I would like to recognise the hard work of Gerry and Camillus and their commitment to the business whilst agreeing to receive shares in lieu of a salary in 2018 and 2019, at a time when the Company was cash constrained, as the Company was turned around and has grown. Furthermore, as a demonstration of their commitment, they have offered to receive a cash payment at a significant discount to settle the shares that they are owed. The Company is in a stable position, both financially and operationally, and under the continued guidance of its executive team, the Board believes that DeepVerge has a strong future ahead."


On 16 July 2018, when the intention to appoint Gerard Brandon and Camillus Glover to the Company's board as Chief Executive Officer and Chief Operations Officer respectively was notified by the Company, the notification included details of remuneration arrangements for Mr Brandon and Mr Glover such that for the first year of their appointment, and in order to preserve the Company's cash balances, their salaries were to be settled by the issue of ordinary shares in the Company ("Ordinary Shares"). The number of new Ordinary Shares to be issued was to be determined on a quarterly basis and issued at the volume weighted average mid-market closing price ("VWAP") of Ordinary Shares for the previous 90 days. Mr Brandon and Mr Glover elected to receive shares in lieu of salary for the period from the date of their appointment as directors, 8 August 2018 until 30 June 2019, being amounts of GBP102,500 and GBP92,250 respectively.

In aggregate, the number of shares due to be issued to Mr Brandon and Mr Glover under the above arrangements are as follows:

       Name          Value of salary          Number of Ordinary         Average price 
                           for which    Shares due in settlement       of shares to be 
                         shares were       of these arrangements      issued (based on 
                          elected to                                   relevant 90 day 
                            be taken                                VWAP calculations) 
 Gerard Brandon           GBP102,500                   1,255,118            8.17 pence 
                   -----------------  --------------------------  -------------------- 
 Camillus Glover           GBP92,250                   1,129,606            8.17 pence 
                   -----------------  --------------------------  -------------------- 
 Total                    GBP194,750                   2,384,724 
                   -----------------  --------------------------  -------------------- 

adjusted for the 10:1 share consolidation in September 2020.

None of the shares due to Messrs Brandon and Glover have yet been issued.

As the issue of shares in lieu of salary is treated by taxation authorities in the United Kingdom (for Mr Brandon) and Ireland (for Mr Glover) as remuneration, income tax and national insurance (or Irish equivalent) contributions for both employer and employee fall due at the date of payment of the remuneration, based upon its value at that date.

The Company's mid-market Ordinary Share price at close of business on 25 November 2021 (the date the Company's Independent directors met to consider this matter) was 27.0 pence, which is a significant premium to the implied price at which the shares would be issued as set out in the table above.

To issue the shares as above would have the following effects on DeepVerge:

- Employers' National Insurance (or Irish equivalent) of GBP40,717 would be payable by the Company;

- DeepVerge would also have to remit income tax and Employees National Insurance contributions to the taxation authorities (and be reimbursed by the Directors concerned);

- 2,384,724 Shares would be allotted, at an effective blended issue price of which has the effect of diluting existing shareholders' holdings by around 1.1%.

It is therefore proposed that instead of settling these amounts by the issue of shares as contracted (which have a market value of GBP643,875), the Directors concerned waive their entitlements to the shares, and instead are paid the salaries to which these relate in cash via DeepVerge's payroll, at a premium of 25% - ie a total of GBP243,438 (compared to the original entitlement of GBP194,750) as set out in the table below.

If DeepVerge were to have issued these shares as at 25 November 2021 the value of the remuneration would be as follows, which is compared to the proposed settlement.

      Name               No of shares      Deemed value of    Proposed settlement 
                    due in settlement      remuneration at    (being a 25% uplift 
                            of salary    25 November 2021*        on the original 
                                                              contracted amounts) 
 Gerard Brandon             1,255,118           GBP338,882     GBP128,125 in cash 
                  -------------------  -------------------  --------------------- 
 Camillus Glover            1,129,606           GBP304,994     GBP115,313 in cash 
                  -------------------  -------------------  --------------------- 
 Total                      2,384,724           GBP643,875     GBP243,438 in cash 
                  -------------------  -------------------  --------------------- 

*this is the gross value of the shares, being the number of shares in the 2(nd) column multiplied by 27.0 pence,

being the closing mid-market price of Ordinary Shares on 25 November   2021. 

Issuing the 2,384,724 shares to which the Directors are entitled would result in a charge to the profit and loss account of GBP684,592 of which GBP643,875 would be a non-cash item (notwithstanding DeepVerge would be required to remit tax and national insurance contributions to the taxation authorities, and be reimbursed for the tax and employees national insurance contributions by the Directors concerned) and GBP40,717 would be a cash item (being the Employers' national insurance contributions).

It is proposed that, rather than settle these amounts by the issue of shares, the Directors concerned waive their rights to the shares, which would have a gross value of GBP643,875 and instead receive cash of GBP243,438 (being GBP128,125 for Mr Brandon and GBP115,313 for Mr Glover.)

The "net" cash cost of the proposed settlement amounts in total to GBP218,115 more than if the original contracted arrangement prevailed, comprising cash paid to the Directors less the incremental Employers' national insurance contributions. The Company concluded a GBP10 million fundraising in June 2021 and is able to meet the extra cash required to effect this settlement from its current resources.

Related party transactions

Under the AIM Rules for Companies ("AIM Rules"), directors of the Company, Gerard Brandon and Camillus Glover are each a related party of the Company, and the intended amendment to the terms of the settlement of the deferred remuneration is treated as a related party transaction.

Under the AIM Rules, where a company enters into a related party transaction, the independent directors of that company are required, after consulting with the company's nominated adviser, to state whether, in their opinion, the transaction is fair and reasonable in so far as its shareholders are concerned.

The Independent Directors, being Ross Andrews, Dr Nigel Burton and Fionan Murray, have considered the terms of the settlement and note the following:

1) In June 2021 the Company raised GBP10 milion in new equity and has the wherewithal to fund the GBP258,832 (including employer taxes) cash cost of this arrangement

2) The incremental cash cost of paying these salaries now is significantly less than the tax and national insurance that would be payable if the shares were issued

3) The settlement effectively amounts to DeepVerge buying back 2,384,724 shares at a blended price of 10.85p per share, which is significantly less than the current share price, and as such saves a dilution to existing shareholders of around 1.1%.

4) The Directors concerned are foregoing (gross) gains on the shares to which they would have been entitled of GBP449,125.

Having consulted with SPARK, the Company's nominated adviser, the Independent Directors of the Company believe that the terms of the settlement are fair and reasonable in so far as the Company's shareholders ("Shareholders") are concerned.

 DeepVerge plc              Ross Andrews, Chairman    +44 (0) 1904 40 4036 
 SPARK Advisory Partners 
  Limited (Nominated        Neil Baldwin / Andrew 
  Advisor)                   Emmott                   +44 (0) 113 370 8974 
                           ------------------------  --------------------- 
 Turner Pope Investments    Andy Thacker / James 
  (TPI) Limited (Broker)     Pope                     +44 (0) 20 3657 0050 
                           ------------------------  --------------------- 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

November 26, 2021 02:00 ET (07:00 GMT)

1 Year Integumen Chart

1 Year Integumen Chart

1 Month Integumen Chart

1 Month Integumen Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220128 13:15:55